Tanya Spektor is the Director of Scientific/Clinical Communications for Oncotherapeutics and oversees and helps develop project-specific strategies and communications. Over the course of her career, she has gained nearly twelve years of medical writing experience, including regulatory affairs. Dr. Spektor is responsible for the work product resulting in publications, and all necessary regulatory and clinical documents. She also has contributed to writing and supporting an extensive repertoire of Investigational New Drug Applications (INDs). Additionally, she is experienced in writing pre-clinical research articles for peer-reviewed journals, scientific reviews, and presentation-related materials. Dr. Spektor works closely with multidisciplinary teams bringing her scientific, therapeutic, clinical, regulatory, and writing expertise to facilitate and ensure quality documentation for successful completion of projects.
Tanya received her Ph.D. in molecular biology and biochemistry from the University of Southern California.